Leidos Holdings, Inc.
—- Market cap
- $16.17B
- Debt
- —
- Cash
- −$1.11B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: LDOS stock price vs WELL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WELL's multiple
Needs WELL P/E.
Implied fair value · at LDOS's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Leidos Holdings, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
WELLTOWER INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTERNATIONAL BUSINESS MACHINES CORP
LDOS vs IBM
Accenture plc
LDOS vs ACN
LOCKHEED MARTIN CORP
LDOS vs LMT
NORTHROP GRUMMAN CORP /DE/
LDOS vs NOC
GENERAL DYNAMICS CORP
LDOS vs GD
ZEBRA TECHNOLOGIES CORP
LDOS vs ZBRA
Ventas, Inc.
LDOS vs VTR
OMEGA HEALTHCARE INVESTORS INC
LDOS vs OHI
COSTAR GROUP, INC.
LDOS vs CSGP
Prologis, Inc.
LDOS vs PLD
Public Storage
LDOS vs PSA
EQUITY RESIDENTIAL
LDOS vs EQR
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe LDOS’s current margin profile and balance-sheet strength are more durable than WELL’s growth-driven multiple premium, then LDOS looks attractive on a relative valuation basis because it trades near its historical range while WELL trades at extreme multiples.
LDOS trades at a steep discount to WELL on both earnings and revenue-based multiples, despite a much lower leverage profile and better profitability. The gap appears driven more by WELL’s much faster growth and asset-heavy REIT-style valuation than by a comparable operating quality premium.
Supporting Metrics